Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recombinant Bovine Viral Diarrhea Virus Envelope Glycoprotein E1 (BVDV gp33), N-His

Cat. No.VG3F74

Product TypeVeterinary Antigens

Size

Product Overview

BioVenic's Recombinant Bovine Viral Diarrhea Virus Envelope Glycoprotein E1 (BVDV gp33), N-His is a recombinant protein expressed from E.coli Expression System. Its predicted molecular weight is 21.0 kDa. The purity is>90% (SDS-PAGE).

Specifications

Type Recombinant Protein
Species Virus
Expression System E.coli Expression System
Purity >90% (SDS-PAGE)
Predicted Molecular Weight 21.0 kDa
Physical State Lyophilized
Formulation PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Target Information

E1 (gp33) is a 33 kDa membrane-anchored structural glycoprotein essential for the Bovine Viral Diarrhea Virus (BVDV) life cycle. It resides primarily in the viral envelope, where it forms covalent disulfide-linked heterodimers with the E2 glycoprotein. This E1-E2 complex is critical for mediating viral entry and membrane fusion with host cells. While less immunodominant than E2, E1 is vital for virion assembly and stability, serving as an important target for research into viral morphogenesis and broad-spectrum pestivirus vaccine design.

Protein Bovine Viral Diarrhea Virus Envelope Glycoprotein E1 (BVDV gp33)
Protein Synonym gp33; BVDV E1; Envelope glycoprotein E1; Viral protein gp33; Pestivirus E1
Gene ID 1489735
UniProt ID P19711

Shipping and Storage

This product is shipped with gel ice bags. Avoid repeated freezing and thawing. Store for 12 months at -20°C or -80°C.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

User Note

  1. Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.
Inquiry Basket